Laminin α1 reduces muscular dystrophy in dy mice
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Matrix Biology
- Vol. 70, 36-49
Abstract
No abstract availableKeywords
Funding Information
- Anna and Edwin Berger Foundation (18771)
- Association Française contre les Myopathies
- Crafoord Foundation
- Greta and Johan Kock Foundation
- Jane and Dan Olsson Foundation
- Olle Engkvist Byggmästare foundation
- Royal Physiographic Society in Lund
- the Swedish Research Council (2014-3420)
- Tore Nilsson Foundation
- Österlund Foundation
This publication has 52 references indexed in Scilit:
- Omigapil Treatment Decreases Fibrosis and Improves Respiratory Rate in dy2J Mouse Model of Congenital Muscular DystrophyPLOS ONE, 2013
- Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-α2-deficient congenital muscular dystrophy (MDC1A)Skeletal Muscle, 2012
- Laminin-111 Protein Therapy Reduces Muscle Pathology and Improves Viability of a Mouse Model of Merosin-Deficient Congenital Muscular DystrophyThe American Journal of Pathology, 2012
- Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dyW mouse model of merosin-deficient congenital muscular dystrophy type 1AJournal of Cell Science, 2011
- Apoptosis inhibitors and mini‐agrin have additive benefits in congenital muscular dystrophy miceEMBO Molecular Medicine, 2011
- Transgenic Expression of Laminin α1 Chain Does Not Prevent Muscle Disease in the mdx Mouse Model for Duchenne Muscular DystrophyThe American Journal of Pathology, 2011
- Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1AHuman Molecular Genetics, 2011
- Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategiesSkeletal Muscle, 2011
- Linker molecules between laminins and dystroglycan ameliorate laminin-α2–deficient muscular dystrophy at all disease stagesJournal of Cell Biology, 2007
- An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophyNature, 2001